GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Revvity Inc (BSP:R1VT34) » Definitions » Other Net Income (Loss)

Revvity (BSP:R1VT34) Other Net Income (Loss) : R$-165 Mil (TTM As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Revvity Other Net Income (Loss)?

Revvity's Other Net Income (Loss) for the three months ended in Mar. 2024 was R$-13 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 was R$-165 Mil.

Revvity's quarterly Other Net Income (Loss) increased from Sep. 2023 (R$-113 Mil) to Dec. 2023 (R$73 Mil) but then declined from Dec. 2023 (R$73 Mil) to Mar. 2024 (R$-13 Mil).

Revvity's annual Other Net Income (Loss) declined from Dec. 2021 (R$304 Mil) to Dec. 2022 (R$296 Mil) but then increased from Dec. 2022 (R$296 Mil) to Dec. 2023 (R$2,516 Mil).


Revvity Other Net Income (Loss) Historical Data

The historical data trend for Revvity's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Revvity Other Net Income (Loss) Chart

Revvity Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Net Income (Loss)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.80 500.72 303.79 296.38 2,516.49

Revvity Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Net Income (Loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,836.76 -111.94 -113.45 73.48 -13.36

Revvity Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was R$-165 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Revvity Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Revvity's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.


Revvity (BSP:R1VT34) Business Description

Traded in Other Exchanges
Address
940 Winter Street, Waltham, MA, USA, 02451
Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.

Revvity (BSP:R1VT34) Headlines

No Headlines